Clinical Trial Update: A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating an investigational measles vaccine (V205C-010) sponsored by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• Measles-Mumps-Rubella investigational vaccine (V205C-010) (Measles-Mumps-Rubella vaccine (investigational))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles | Phase 2 | Status: COMPLETED